The finest Non-Ionizing Breast Imaging Market research report gives complete overview of the industry and its various aspects that range from product definition, customary vendor landscape, to market segmentation that is based on various parameters such as type of product, its components, type of management and geography. It studies comprehensive evaluation of the market growth predictions and restrictions. An analytical assessment of the competitors gives clear idea of the most important challenges faced by them in the current market and in the upcoming years. The world class Non-Ionizing Breast Imaging Market report is very supportive for customers or other market participants get aware of the problems that may arise while operating in industry over a longer period of time.
Global Non-Ionizing Breast Imaging Market Analysis and Size
The non-ionizing breast imaging market was valued at USD 4.02 billion in 2021 and is expected to reach USD 7.77 billion by 2029, registering a CAGR of 8.60% in 2022-2029. The “breast ultrasound” accounts for the largest type segment in the non-ionizing breast imaging market within the forecasted period owing to the lower risk of exposure to radiation and the various benefits such as the ability to detect lesions and the ability to differentiate between a cyst and a solid mass and the detection of blood flow through vessels. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-ionizing-breast-imaging-market
What is more, the market research data of an excellent Non-Ionizing Breast Imaging Market report is interpreted by using established and advanced tools such as SWOT analysis and Porter’s Five Forces Analysis. The key areas included in the report are market definition, market segmentation, competitive analysis and research methodology. This market report also enlists the major competitors along with the strategic insights and analysis of the key factors influencing the industry. For a booming business, it is quite essential to get knowledgeable about consumer’s demands, preferences, attitudes and their varying tastes about the particular product. And the winning Non-Ionizing Breast Imaging Market report is right there to solve this purpose comprehensively.
Global Non-Ionizing Breast Imaging Market, By Type (Breast Ultrasound, Breast MRI, Automated Whole-breast Ultrasound (AWBU), Breast thermography, Electric Impedance Tomography, Optical Imaging), End User (Hospital, Diagnostic Imaging Centre, Others) – Industry Trends and Forecast to 2029.
According to the World Health Organization (WHO), breast cancer is the second most common cancer among women, and more than 200,000 new cases of cancer are diagnosed every year worldwide. The rising incidence of breast cancer has further increased awareness of breast cancer early detection across the globe. As a result, supportive government initiatives aid in spreading awareness about cancer risk factors, preventive measures and early detection. Consequently, these growth determinants will fuel the expansion of the market over the forecasted period.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The non-ionizing breast imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for non-ionizing breast imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the non-ionizing breast imaging market. The data is available for historic period 2010-2020.
Competitive Landscape and Non-Ionizing Breast Imaging Market Share Analysis
The non-ionizing breast imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to non-ionizing breast imaging market.
Some of the major players operating in the non-ionizing breast imaging market are
- Hologic, Inc. (U.S.)
- General Electric (U.S.)
- Siemens (Germany)
- Koninklijke Philips N.V. (Netherlands)
- Fujifilm Holdings Corporation (Japan)
- Canon Inc. (Japan)
- Aurora Healthcare US Corp. (U.S.)
- Allengers (India)
- Dilon Medical Technologies, Inc. (U.S.)
- Siemens (Germany)
- Planmed Oy. (Finland)
- Delphinus Medical Technologies, Inc. (U.S.)
- Micrima Limited (U.K)
- CMR Naviscan Corporation (U.S.), SuperSonic Imagine (France)
- Carestream Health (U.S.)
Global Non-Ionizing Breast Imaging Market Definition
Breast imaging is a diagnostic radiology subspecialty that involves imaging breasts for diagnostic or screening purposes. Breast imaging technologies are used to study the tissues of women’s breasts in order to diagnose breast cancer and other breast-related diseases. Some of the most popular breast imaging examinations include mammograms, breast magnetic resonance imaging (MRI), and ultrasound.
Non-Ionizing Breast Imaging Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Requirement for Diagnosis
The rising prevalence of breast cancer is the most significant factor driving the growth for this market as it further requires diagnosis and screening. The increasing population of women who are more susceptible to breast cancer is also projected to bolster the market’s growth.
Furthermore, the expanding healthcare sector along with the rise in demand for early diagnosis are also expected to fuel market growth. Moreover, the increasing number of screening programs, as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis, also cushions the market’s growth within the forecasted period.
Opportunities
- Improving Reimbursement, Funding and Investments
Moreover, the improving reimbursement scenario and increase in funding from private and government organizations for the development of healthcare infrastructure are estimated to generate lucrative opportunities for the market. The growing government and private investments to meet the increasing demand for breast cancer screening will further offer numerous growth opportunities for the market.
Restraints/Challenges Global Non-Ionizing Breast Imaging Market
- High Costs
On the other hand, the high cost required for detecting breast cancer is expected to obstruct market growth.
- Effects of Radiation
The adverse effects from exposure to radiation leads to the lesser population turn up for the procedure. This factor is estimated to impede the overall growth of the market.
- Strict Regulations
Also, the stringent regulatory approval procedures are projected to challenge the non-ionizing breast imaging market in the forecast period of 2022-2029.
This non-ionizing breast imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.
Table of Contents:
- Introduction
- Market Segmentation
- Market Overview
- Executive Summary
- Premium Insights
- By Component
- Product Type
- Delivery
- Industry Type
- Geography
- Overview
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
- Company Landscape
- Company Profiles
- Related Reports
For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-non-ionizing-breast-imaging-market
Post Covid-19 Impact on Non-Ionizing Breast Imaging Market
The emergence of COVID-19 pandemic put a strain on healthcare systems all around the world. The non-ionizing breast imaging market was largely impacted by the outbreak of COVID-19.
During the pandemic, the imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales further limits the industry’s expansion. The implementation of lockdown resulted in a decrease in the number of patient visits for other diseases such as cancer and diabetes. According to the Eurasian Journal of Medical Investigation (EJMI), between April and July 2020, there was a 41.7 percent -64.4 percent reduction in the number of breast imaging modalities. The mammography technology showed the most significant decline. The mammography technology showed the most significant decline.
Recent Developments
- In April 2021, Seno Medical’s Imagio P200003 Breast Imaging System has been authorized by the US Food and Drug Administration (FDA). The Imagio Breast Imaging System images breast tissues using both optoacoustic (OA) and ultrasound (US) technology to assist clinicians in examining breast abnormalities.
- In April 2021, Dilon Technologies Inc., the owner of the Navigator Gamma Probes and a world-class global leader in breast cancer therapy and detection, has acquired all of Dune Medical’s assets, including Dune Medical’s “MarginProbe essentially.”
Global Non-Ionizing Breast Imaging Market Scope
The non-ionizing breast imaging market is segmented on the basis of type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Breast Ultrasound
- Breast MRI
- Automated Whole-breast Ultrasound (AWBU)
- Breast thermography
- Electric Impedance Tomography
- Optical Imaging
On the basis of type, the non-ionizing breast imaging market is segmented into breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography and optical imaging. The breast ultrasound segment is projected to account for the largest share owing to the lower risk of exposure to radiation and the various benefits such as the ability to detect lesions and the ability to differentiate between a cyst and a solid mass and the detection of blood flow through vessels.
End User
- Hospital
- Diagnostic Imaging Centre
- Others
On the basis of end user, the non-ionizing breast imaging market is bifurcated into hospital, diagnostic imaging centre and others.
Read more@ https://www.databridgemarketresearch.com/reports/global-non-ionizing-breast-imaging-market
Browse More Reports:-
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email @ Corporatesales@databridgemarketresearch.com
